Saturday, August 13, 2016

Antidepressive treatment during pregnancy can affect newborn brain activity

http://www.eurekalert.org/pub_releases/2016-06/uoh-atd061516.php

Public Release: 15-Jun-2016
Antidepressive treatment during pregnancy can affect newborn brain activity
University of Helsinki

According a new study, fetal exposure to commonly used SRI drugs may affect brain activity in newborns. The researchers suggest that the effects of drugs on fetal brain function should be assessed more carefully, Indications for preventive medication should be critically evaluated, and non-pharmacological interventions should be the first-line treatment for depression and anxiety during pregnancy.

"We found many changes in the brain activity of SRI-exposed newborns," says Professor Sampsa Vanhatalo, head of the BABA center at the Helsinki University Children's Hospital. "Since the changes did not correlate with the mother's psychiatric symptoms, we have assumed that they resulted as a side effect of maternal drug treatment."

•••••

It is estimated that up to 5% of all pregnant women use SRI medication.

However, several animal studies have shown that early SRI exposure may result in microscopic changes in fetal brain structure, as well as altered neuronal signaling. The already known side effect of this on human newborns is the transient 'SRI syndrome,' including such symptoms as respiratory problems during the first days of life. In addition, a recent Finnish long-term follow-up study conducted at the Universities of Helsinki and Turku showed that fetal exposure to SRI drugs increases the risk of childhood depression.

•••••

"The most interesting aspect in our observations is that comparable effects were recently found in animal experiments after fetal SRI exposure," says principal investigator Dr. Mari Videman, senior consultant in child neurology. "This suggests that the early SRI effects on brain development may be comparable in humans and other species."

•••••

No comments:

Post a Comment